Physician

Jyoti Shah

According to 2025 Medicare claims, Jyoti Shah (NPI: 1922027754) practices pulmonary disease in the Lexington Park, MD market, with the plurality of this provider's patient population coming from St. Marys, MD. This provider's primary affiliated billing organization is MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (NPI: 1831592211; TIN: 462691028) and primary practice location at 20636-7871.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,217 traditional Medicare patients, billed 3,380 HCPCS/CPT codes, and received $286,067 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,711 prescription claims across 597 beneficiaries totaling $1,758,747 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 6,808 claims. Open Payments data shows 10 records totaling $272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $164,276 to $286,067. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $425,021 to $1,758,747. For DME billing, reported payments moved sharply higher in recent years, from $131,625 to $474,074.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	759	2,282	$164,276
2016	866	2,883	$211,358
2017	1,034	3,421	$242,315
2018	1,105	3,962	$314,300
2019	1,244	4,548	$331,643
2020	991	2,891	$205,780
2021	1,092	3,518	$324,331
2022	1,194	3,775	$337,993
2023	1,300	3,584	$327,184
2024	1,217	3,380	$286,067

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	241	1,566	$425,021
2016	264	1,917	$445,629
2017	317	2,338	$571,242
2018	383	3,059	$728,324
2019	452	3,395	$1,254,275
2020	411	3,538	$1,132,553
2021	424	3,534	$889,352
2022	467	3,738	$962,469
2023	521	4,011	$1,413,213
2024	597	4,711	$1,758,747

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	495	2,089	$176,309
2016	703	2,563	$144,468
2017	792	2,902	$137,257
2018	1,069	3,935	$194,981
2019	1,562	5,555	$242,261
2020	1,518	5,807	$338,169
2021	1,748	6,521	$409,933
2022	1,740	6,471	$435,345
2023	1,823	6,535	$474,411
2024	1,865	6,808	$511,904

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	264	264	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	694	1,021	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	330	396	$62
94726	Test to determine lung volumes using sensors	190	192	$42
94060	Test to measure expiratory airflow and volume changes before and after medication administration	210	214	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	431	14,940	$313,860
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	289	9,810	$202,337
Dupixent Pen	Dupilumab	44	1,218	$178,477
Tezspire	Tezepelumab-Ekko	40	1,138	$167,208
Dupixent Syringe	Dupilumab	22	616	$82,863

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	240	1,872	$126,248
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	15	130	$111,818
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	17	97	$91,155
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	39	$29,662
E1392	Portable oxygen concentrator, rental	Y	80	620	$22,124

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$272	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jyoti Shah?

Tedicare shows public-source Medicare data for Jyoti Shah (NPI 1922027754), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jyoti Shah have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jyoti Shah?

Jyoti Shah is linked to MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (billing NPI 1831592211) in the available physician profile data.

Does Jyoti Shah have Open Payments data?

Jyoti Shah has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.